Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP286423.RA9ERwv-EdbrrJV6SbaOCOALQiMDxL2wii4-BGuq0W7nE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP286423.RA9ERwv-EdbrrJV6SbaOCOALQiMDxL2wii4-BGuq0W7nE130_assertion type Assertion NP286423.RA9ERwv-EdbrrJV6SbaOCOALQiMDxL2wii4-BGuq0W7nE130_head.
- NP286423.RA9ERwv-EdbrrJV6SbaOCOALQiMDxL2wii4-BGuq0W7nE130_assertion description "[Although further tests with primary tumor tissues are required, the unexpected correlation between ER status and Src/PTP alpha dependence in breast cancer cell lines may be important for planning therapeutic strategies, and the insensitivity of normal breast cells to the RNAi highlights the potential of PTP alpha, which may be easier to target than Src, as a therapeutic target in ER-negative breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP286423.RA9ERwv-EdbrrJV6SbaOCOALQiMDxL2wii4-BGuq0W7nE130_provenance.
- NP286423.RA9ERwv-EdbrrJV6SbaOCOALQiMDxL2wii4-BGuq0W7nE130_assertion evidence source_evidence_literature NP286423.RA9ERwv-EdbrrJV6SbaOCOALQiMDxL2wii4-BGuq0W7nE130_provenance.
- NP286423.RA9ERwv-EdbrrJV6SbaOCOALQiMDxL2wii4-BGuq0W7nE130_assertion SIO_000772 18183590 NP286423.RA9ERwv-EdbrrJV6SbaOCOALQiMDxL2wii4-BGuq0W7nE130_provenance.
- NP286423.RA9ERwv-EdbrrJV6SbaOCOALQiMDxL2wii4-BGuq0W7nE130_assertion wasDerivedFrom befree-20140225 NP286423.RA9ERwv-EdbrrJV6SbaOCOALQiMDxL2wii4-BGuq0W7nE130_provenance.
- NP286423.RA9ERwv-EdbrrJV6SbaOCOALQiMDxL2wii4-BGuq0W7nE130_assertion wasGeneratedBy ECO_0000203 NP286423.RA9ERwv-EdbrrJV6SbaOCOALQiMDxL2wii4-BGuq0W7nE130_provenance.